Home › Geron's Much Anticipated Imetelstat Phase 2 Study Grows To 50 Locations And Begins Enrollment
 

Keywords :   


Geron's Much Anticipated Imetelstat Phase 2 Study Grows To 50 Locations And Begins Enrollment

2015-07-18 19:52:36| Biotech - Topix.net

Geron and partner Johnson & Johnson missed their self-imposed target date for the start of trial enrollment, yet Geron's stock hit its 52-week high post the deadline. I am speculating the delay may be driven by JNJ laying the groundwork for a possible Breakthrough Drug Therapy designation for Imetelstat.

Tags: study locations phase begins

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11PM responds to Sir Alan Bates after repeated requests
05.11American Angus elects 2024-25 board leaders
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 8A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Brazil gives green light to medicinal use of Cannabis in animals
More »